Trastuzumab for Her2/neu-positive metastatic salivary gland carcinoma: Case report and review of the literature
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Trastuzumab for Her2/neu-positive metastatic salivary gland carcinoma: Case report and review of the literature ; volume:2 ; number:03 ; year:2012 ; pages:71-73
Avicenna journal of medicine ; 2, Heft 03 (2012), 71-73
- Beteiligte Personen und Organisationen
-
Firwana, Belal
Atassi, Bassel
Hasan, Rim
Hasan, Nour
Sukari, Ammar
- DOI
-
10.4103/2231-0770.102282
- URN
-
urn:nbn:de:101:1-2021090814560621436370
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Firwana, Belal
- Atassi, Bassel
- Hasan, Rim
- Hasan, Nour
- Sukari, Ammar
Ähnliche Objekte (12)
Second-Line Treatment of HER2-Positive Salivary Gland Tumor: Ado-Trastuzumab Emtansine (T-DM1) after Progression on Trastuzumab
Genomic characteristics of trastuzumab-resistant Her2-positive metastatic breast cancer
Systemic therapy for recurrent or metastatic salivary gland malignancies
Salivary gland neoplasms
Salivary Gland Cytopathology
Salivary Gland Scintigraphy in the Evaluation of Salivary Gland Dysfunction
Systemic therapy for metastatic salivary gland tumors—challenges and novel concepts
Trastuzumab therapy duration in HER2-positive de novo metastatic breast cancer: 1999–2018
Salivary gland tumors : 52 tables
Bioengineering in salivary gland regeneration
Salivary gland diseases in children
Pictorial essay: Salivary gland imaging
Second-Line Treatment of HER2-Positive Salivary Gland Tumor: Ado-Trastuzumab Emtansine (T-DM1) after Progression on Trastuzumab
Genomic characteristics of trastuzumab-resistant Her2-positive metastatic breast cancer
Systemic therapy for recurrent or metastatic salivary gland malignancies
Salivary gland neoplasms
Salivary Gland Cytopathology
Salivary Gland Scintigraphy in the Evaluation of Salivary Gland Dysfunction
Systemic therapy for metastatic salivary gland tumors—challenges and novel concepts
Trastuzumab therapy duration in HER2-positive de novo metastatic breast cancer: 1999–2018
Salivary gland tumors : 52 tables
Bioengineering in salivary gland regeneration
Salivary gland diseases in children
Pictorial essay: Salivary gland imaging
Second-Line Treatment of HER2-Positive Salivary Gland Tumor: Ado-Trastuzumab Emtansine (T-DM1) after Progression on Trastuzumab
Genomic characteristics of trastuzumab-resistant Her2-positive metastatic breast cancer
Systemic therapy for recurrent or metastatic salivary gland malignancies
Salivary gland neoplasms
Salivary Gland Cytopathology
Salivary Gland Scintigraphy in the Evaluation of Salivary Gland Dysfunction
Systemic therapy for metastatic salivary gland tumors—challenges and novel concepts
Trastuzumab therapy duration in HER2-positive de novo metastatic breast cancer: 1999–2018
Salivary gland tumors : 52 tables
Bioengineering in salivary gland regeneration
Salivary gland diseases in children